Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative goal-directed fluid therapy with two prophylactic norepinephrine doses in elderly spinal surgery patients
ChiCTR1900021309Phase 4Not yet recruiting
- Sponsor
- Xuanwu Hospital
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of norepinephrine in Back disorder (2 arms), sponsored by Xuanwu Hospital. Primary endpoint: Incidence of postoperative complications. Planned start Mar 2019; status: not yet recruiting.
02
Drugs
norepinephrine
03
Conditions
Back disorder
Beyond the preview
Go deeper on ChiCTR1900021309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021309.